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Abstract
Background: Sports related injuries such as lower limb tendinopathies can result in long-standing impairment of
athletic performance. In recent years, treatment interventions like eccentric exercises, Platelet Rich Plasma (PRP)
injections and Extracorporeal Shockwave Therapy (ESWT) have gained popularity among Physiotherapists and
sports clinicians, but the evidence of their effectiveness is very limited.
Purpose: To investigate the effectiveness of ESWT on Achilles and Patellar tendinopathy.
Methods: A systematic review and meta-analysis was conducted using MEDLINE, EMBASE, AMED, CINAHL,
PEDro and Cochrane databases and bibliographic searches from inception until April 2013 to identify randomized
control trials comparing ESWT with other treatment methods.
Results: Of 306 titles screened, 9 papers, including 487 patients were included in this review. Meta-analysis
showed no significant differences between the intervention and control group on the pooled VISA-A scores (p=0.59,
95% CI-15.02, 26.51) or load-induced pain (p=0.51, 95% CI-3.15, 1.56) for Achilles tendinopathy and no significant
differences between the pooled VISA-P scores for patellar tendinopathy (p=0.27, CI-7.86, 27.87).
Conclusions: The meta-analysis did not demonstrate a statistically significant improvement in symptoms or load
induced pain for ESWT compared to other treatments or control. Adequately powered, high quality studies with
longer follow-ups are required.
Keywords: Shockwave; Tendinopathy; Extracorporeal shockwave
therapy
Introduction
Sports related injuries are a constant and disturbing problem for
both clinicians and athletes. Among these, overuse injuries may
constitute 30-50% of all injuries [1]. Tendon injuries could be either
acute or chronic in nature and the choice of treatment would depend
on the specific pathology and diagnosis of the condition. Traditionally,
emphasis was given on targeting inflammation. However, there has
been considerable advancement in the management of tendon
disorders in recent years. With the term ‘tendinosis’ and ‘tendinopathy’
replacing ‘tendinitis’ [2] treatment interventions like Eccentric
exercises, Platelet Rich Plasma (PRP) and Extracorporeal Shockwave
Therapy (ESWT) has gained popularity among sports clinicians in
treating tendon related pathologies.
Extracorporeal shockwave therapy (ESWT) is a non-invasive
treatment in which a device is used to pass acoustic shockwaves
through the skin to the affected area of the body. Similar use of high
energy sound waves is seen in lithotripsy for the breakdown of kidney
or gall stones [3]. ESWT can be applied in different energy levels over
one or more sessions and as high energy ESWT can be painful, is
sometimes applied with anesthesia. ESWT is used in the treatment of
musculoskeletal conditions such as chronic proximal plantar fasciitis
[4] and lateral epicondylitis [5]. However, guidelines for its use in the
UK currently recommend use limited to certain conditions or
restricted to clinical trials (NICE 2009).
Previous systematic reviews [6] have identified a number of studies
on ESWT for lower limb tendinopathies, however these reviews have
been limited by the inclusion of relatively few studies with small
numbers of patients, potential selection bias (limitedscope/databases/
publication bias) and potential reporting bias. Consequently, current
evidence to guide clinical practice is inconclusive. This systematic
review attempts to address a number of these limitations in the
question: ‘Is Extracorporeal Shock Wave Therapy more effective than
standard care or other interventions in improving pain and function in
the management of Achilles and Patellar tendinopathies?’
Methods
We conducted a systematic review of the literature using
standardised methods [7,8] Components of the research question were
classified according the PICO acronym [9] P (Population)-adult
humans with achilles and patellar tendinopathy; I (Intervention)-
ESWT, which can be generated by different methods [10]. C
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(Contrast)-compared to “standard care” or another intervention; O
(Outcomes) of key interest was reduction in pain and increase in
function measured at any time after treatment.
Literature search
We searched multiple databases: MEDLINE, CINAHL Plus,
EMBASE, AMED, SPORTDiscus and PEDro, from their inception to
April 2013. We also searched the Cochrane Trials Register, the ISI Web
of Science, International Standard Randomised Control Trial Number
(ISRCTN) register and the National Institute of Health (NIH) clinical
trials register to identify unpublished studies. Medical Sub Heading
(MeSH) terms and keywords including tendon* or tendin* and
intervention-specific words shockwave* OR “shock wave*”were used
(See search strategy Supplementary Data). Reference lists from articles
were hand-searched to check for relevant articles not previously
identified.
Eligibility criteria
We included all randomised control trials (RCT) comparing ESWT
to other interventions reported in the English language. We included
studies using Focused Shockwave (FSWT) and Radial Shockwave
(RSWT) delivery methods, delivered with or without anaesthetic.
Studies on both mid-portion and insertional tendinopathies were
included. Exclusion criteria included non-human animal studies and
studies involving anatomical structures other than tendon.
Selection of studies
Titles and abstracts from the search strategy were assessed by AP
and in uncertain cases assessed by AN. A third reviewer (KP) acted as
referee in cases of disagreement. Full-text versions of papers were
obtained to confirm eligibility.
Data extraction
Extraction of published data on mean effects and standard
deviations was performed by AP and confirmed by AN and KP.
Outcome measures
The two main outcomes of interest were function and tendinopathic
pain, measured at any time point after the intervention.
We considered outcome in terms similar to the three main domains
in the Victorian Institute of Sports Assessment (VISA) score: pain,
functional status and the ability to undertake sports [11]. Visentini et
al. considered these domains important in lower limb tendon
pathology. ‘VISA-P’ (Patellar) was converted to a version for Achilles
tendon symptoms ‘VISA-A’ (Achilles) while retaining validity and
reliability by Robinson et al. [12].
A reduction in pain, typically recorded on the Visual Analogue Scale
(VAS) [13] or Numerical Rating Scale (NRS) [14] whilst loading the
tendon was considered a favourable outcome [15].
Secondary outcome measures
Functional objective measures like range of motion and strength
were analysed where available. Other outcomes included a change in a
tendon’s structure or diameter (indicators of tendon pathology)
measured using ultrasonography [16,17].
Methodological quality of the included studies
Included studies were assessed by AP for methodological quality
and validity using the Physiotherapy Evidence Database (PEDro) 11-
point rating scale [18,19]. The maximum score achievable on a PEDro
scale is 10/10 as the first criterion, which measures the external validity
of a trial, is not included in the final score. We classified studies as high
quality (score of 6 or above) or low-quality (score below 6).
Analysis
Summary descriptions of the studies were tabulated. If aggregate
data were considered suitable by the authors, we planned to carry out a
meta-analysis using Review Manager 5.2. To produce forest plots,
calculate summary effects sizes with 95% confidence interval (CI) for
effect of ESWT on function and pain.
We identified a priori subgroups of interest as “patellar” and
“Achilles” studies and those using Focused Shockwave (FSWT) and
Radial Shockwave (RSWT) delivery methods. Our approach would be
dependent on the risk of bias and estimated levels of heterogeneity
being less than 70%. Results are reported in accordance with the
Preferred Reporting Item for Systematic Reviews and Meta-Analyses
(PRISMA) guidance [20].
Results
Study selection
Study selection is shown in Figure 1 with nine studies meeting the
inclusion criteria. Searching reference lists of key articles yielded one
relevant study [21] not identified in the electronic search.
Figure1: Study selection.
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Study characteristics
Table 1 and 2 describe study characteristics for the Achilles and
patellar studies respectively. Generally, mean age in the Achilles studies
was greater than the patellar studies, with most studies having more
women than men. All studies included patients with symptoms of at
least three months duration.
Autho, Year Group
Number of
Patients
and Sex
(M)
Mean
Age
(range
± SD)
Duration of
symptoms
Numbe
r of
session
s
Interval
between ECSW
sessions
Shockwave
application
and Energy
level
(mJ/mm2) x
Impulses
Co-
interventions
allowed
during study
period
Length of
follow up
Significant
differences in
advantage of
ESWT
Peers [21], 2003
(Insertional and
non-insertional)
ESWT 20 (12) 45 (14)
>3 months 3 1 week Focused0.2×1000
Eccentric
exercises at
week 2
2,6 and 12
weeks
Yes at 12
weeks 2,6
weeks NRPlacebo 19 (10) 44 (13)
Costa et al. [22],
2005 (Insertional
and non-
insertional)
ESWT 22 (9) 58.7(10.8)
>4 months 3 1 month Focused0.2×1500 None reported
12weeks
and 1 year
No at 12
weeks 1 year
NRPlacebo 27 (12) 47.7(13.5)
Rompe et al.
[24], 2007 (Non-
insertional)
1.ESWT 25 (11) 51.2(10.3)
>6 months
3 1 week Radial0.1×2000
Crossover
was allowed
after 16 weeks
follow-up
16 weeks
and 1 year
No at 16
weeks (1 vs.
2) Yes at 162.EE 25 (9) 48.1(9.9)
3.Wait
and see 25 (9)
46.4
(11.4)
Twice/day, 12
weeks
weeks (1 vs.
3) 1 year NR
Rasmussen et
al. [23], 2008
(Not-specified)
ESWT 24 (12) 49 (9)
>3 months 4 1 week Radial 0.12 to0.5×1500
Eccentric
training and
stretching
8 and12
weeks
No at 8 and
12 weeksPlacebo 24 (8) 46 (13)
Rompe et al.
[35], 2008
(Insertional)
ESWT 25 (9) 40.4(11.3)
>6 months
3
1 week Radial0.12×2000
Crossover
was allowed
after 16 weeks
follow-up
16 weeks
and 15
months
Yes at 16
weeks 15
months NREE 25 (11) 39.2(10.7)
Twice/d
ay
ESWT=Shock wave therapy, EE=Eccentric exercises, NR=Not reported
Table 1: Randomised control trials comparing shock wave to other interventions for achilles tendinopathy.
Among the five Achilles studies, two studies included patients with
both insertional and non-insertional tendinopathy [21,22]. Among
these studies, Peers [21] was the only study that reported a separate
analysis of both groups (insertional and non-insertional). Rasmussen,
Christensen [23] did not specify the type or location of the Achilles
tendinopathy.
Author Group
Number
of
Patients
and Sex
(M)
Mean Age
(range ±
SD)
Duration
of
symptom
s
Numbe
r of
session
s
Interval
between
ECSW
sessions
Shockwave
application and
Energy level
(mJ/
mm2)xImpulses
Co-interventions
allowed during
study period
Length of
follow up
Significant
differences in
advantage of
ESWT
Taunton [36]
ESWT 10 (5)
(23-52) >3months 03-May 1 week
Focused
0.17×2000 None reported 12 weeks YesPlacebo 10 (5)
Peers [21]
ESWT 23 (19) 29 (8) >3
months 3 1 week
Focused
0.2×1000
Eccentric
exercises at week
2
2,6 and 12
weeks YesPlacebo 22 (18) 31 (8)
Wang et al.
[26]
ESWT 29 (14) 33knees 29.4 (10.5)
>6
months
01-Feb 4-6 weeks
Focused
0.18×1500 None
1,3,6 and 12
months
Yes except for
diameter and
appearance of the
tendon
Control
group
NSAID’s,
24 (13) 25
knees 32.2 (10.4) NR NR
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PT, EE,
strapping
Zwerver et al.
[33] 
ESWT 31 (20) 24.2 (5.2) >3
months 3 1 week
Focused
0.5×2500 None
 1,12 and 22
weeks NoPlacebo 31 (21) 25.7 (4.5)
Vetrano et al.
[37]
ESWT 23 (20) 26.8 (8.5)
>6
months
3 48-72hours Focused 0.17 to
0.25×2400
Stretching,
Strengthening
exercises in both
groups
+Hydrotherapy
2,6 and 12
months No
PRP 23 (17) 26.9 (9.1) 2 1 week
EE=Eccentric ex, NSAID=Non-steroidal anti-inflammatory drugs, PT=Physiotherapy, PRP=Platelet-rich plasma, NR=Not reported
Table 2: Randomised control trials comparing shock wave to other interventions for patellar tendinopathy.
In the Achilles studies patients were requested to refrain for any
other treatments like physiotherapy, insoles or non-steroidal anti-
inflammatory drugs (NSAID’s). Both studies by Rompe et al. permitted
crossover at 16 weeks. Wang et al. and Zwerver et al. permitted
participants in the treatment group to take analgesics post-application
of ESWT as necessary. Taunton et al. did not report the use of any such
medications.
The level of sport participation varied among the study samples. In
the study by Costa, Shepstone [22], almost 79.5% of participants were
involved in some sport, compared to only 30% of participants in the
study by Rompe et al. [24]. Both Peers [21] and Rasmussen,
Christensen [23] did not report participation in sport.
All five patellar studies recruited active sport participants with
Zwerver et al. recruiting subjects who participated in sports with
highly repetitive loading of the patellar tendon (basketball, volleyball
and handball) and permitting subjects to train during the study period.
None of the Achilles or Patellar studies utilized local anaesthetic for
the application of shock waves.
Report of Adverse Events
Adverse events were reported in the Achilles studies: Two older
patients (62 and 65 years) in the study by Costa et al. [22] ruptured
their Achilles tendon. This could be considered as a serious adverse
event. Some subjects receiving ESWT had reddening of the skin after
low-energy SWT (n=25) [24]. No adverse events were reported in the
Patellar studies.
Quality of Studies
Table 3 summarizes the methodological quality of the included
studies using the PEDro scale. Effective subject blinding was achieved
in all studies apart from one [22] whereas, assessor blinding was
achieved in all studies.
 1 2 3 4 5 6 7 8 9 10 11 Total Score
Achilles
Taunton et al. (2003) Yes Yes No No Yes No Yes Yes No Yes No 5/10
Peers (2003)-Achilles tendon Yes Yes Yes Yes Yes No Yes Yes No Yes Yes 8/10
Peers (2003)-Patellar tendon Yes Yes Yes Yes Yes No Yes Yes No Yes Yes 8/10
Costa et al. (2005) Yes Yes Yes No No No Yes Yes No Yes Yes 6/10
Wang et al. (2007) Yes No No Yes No No Yes Yes No Yes Yes 5/10
Patellar
Rompe et al.(2007) Yes Yes Yes Yes No No Yes Yes Yes Yes Yes 8/10
Rasmussen et al. (2008) Yes Yes Yes Yes Yes No Yes Yes Yes Yes Yes 9/10
Rompe et al. (2008) Yes Yes Yes Yes No No Yes Yes Yes Yes Yes 8/10
Zwerver et al. (2011) Yes Yes Yes Yes Yes No Yes Yes Yes Yes Yes 9/10
Vetrano et al. (2013) Yes Yes No Yes No No Yes Yes Yes Yes Yes 7/10
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1. Eligibility criteria specified 2. Random allocation 3. Concealed allocation 4. Baseline prognostic heterogeneity 5. Subject blinding 6. Therapist blinding 7. Assessor
blinding 8. Outcomes obtained for >85% of initially allocated subjects 9. Intention to treat analysis 10. Between groups statistical comparisons reported 11. Point
measures and measures of variability provided (PEDro, 1999).
Table 3: Methodological Quality of Included Trials.
Synthesis of Results
We conducted exploratory meta-analyses in an attempt to pool
results for VISA-A, load induced pain and tenderness outcomes for
Achilles and VISA-P outcomes for Patellar studies (Figure 2-5)
however in all cases heterogeneity was considered to be high (I2 range
71% to 92%). An I2 value of 75% and above is considered high and this
in turn would affect the generalisibity of the findings of meta-analysis
[25]. Pooled estimates were non-significant with confidence intervals
crossing the line of no effect. These results must be considered as
exploratory and interpreted with caution.
Figure 2: VISA-A at 16 weeks.
Figure 3: Load induced pain on Numerical rating scale (NRS) at 16
weeks.
Figure 4: Tenderness at 3 kg on Numerical rating scale (NRS) at 16
weeks.
Figure 5: Improvement in VISA-P score at 12 week.
Tendon diameter on ultrasound scan was assessed in two studies
[24,26] with contradicting results. To detect a significant difference in
tendon structure post-treatment, a study might have to have a longer
follow-up. Studies in the past that reported similar reduction in tendon
thickness had a mean follow-up of more than three years [16,17]
whereas studies included in this review had a mean follow-up of one
year.
The studies on the Achilles tendinopathy did not report any
statistically significant difference between groups with regards to
functional objective measures whereas all Patellar studies included in
this review reported functional improvement.
Discussion
These findings suggest that ESWT was not able to demonstrate a
statistically significant improvement in VISA or load induced pain by
meta-analysis compared to other treatments like eccentric exercises.
Following meta-analysis, there were no significant differences between
the intervention and control group on the pooled VISA-A scores
(p=0.59, 95% CI-15.02, 26.51) or load-induced pain (p=0.51, 95%
CI-3.15, 1.56) at 16 weeks for Achilles tendinopathy and no significant
differences between the pooled VISA-P scores for patellar
tendinopathy at 12 weeks (p=0.27, CI-7.86, 27.87).
Strengths and limitations of this study
Overall, the number of trials in this field is small and studies feature
relatively small sample sizes. However, the included studies
demonstrated reasonable quality with the PEDro score ranging from
five to nine out of ten.
Our review was performed systematically and searched for both
published and unpublished studies in a range of databases to try to
provide a broad review of the trials of ESWT on lower limb
tendinopathies. We included outcomes considered to be clinically
relevant to healthcare providers and patients.
Our review has some limitations: Excluding studies published in
languages other than English could lead to language bias. Additionally,
study selection at the title and abstract stage was performed by one
researcher (potentially resulting in selection bias) although they were
supported by others to discuss uncertain cases and to confirm
inclusion at full text stage. However within our resources every effort
was made to minimise any systematic bias in this review.
Clinical implications
Interest and literature around ESWT is growing steadily and its use
is established in in treating calcific tendinitis of the shoulder [27] and
plantar fasciitis [28].
The included studies were heterogeneous in nature and therefore the
results from the meta-analysis should be interpreted with caution. It
remains largely unclear what parameters are the most important in
using ESWT. Some studies utilised focussed and others radial ESWT.
Intensities, interval between treatments and the total number of
sessions also varied across the studies. Studies typically followed up
subjects in the short to medium term and long-term effects are unclear.
A systematic review on calcific tendinitis of the shoulder also
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questioned the long-term effectiveness of ESWT [29]. Optimising the
dose, delivery and timing of ESWT requires further investigation.
Furthermore, studies included in this review showed better results
when eccentric exercises where introduced as co-interventions [21,23].
This finding is consistent with an earlier systematic review in chronic
Achilles tendinopathy: by Al-Abbad and Simon [6]. Eccentric exercises
might assist in maintaining the effects of ESWT in the long-term.
However, this theory warrants further investigation.
None of the studies included in this review utilised anaesthesia for
the application of ESWT. The use of anaesthesia has been seen to
reduce the effectiveness of ESWT in previous studies [30-32].
Complications can occur with ESWT. These are reported as
erythema and inflammation [24] and Achilles tendon rupture in older
patients [22]. Longer term monitoring for safety in greater numbers of
patients would provide further information on risks associated with
the intervention.
Concurrent sports participation is another factor which may affect
the effectiveness of ESWT. Subjects in the study by Zwerver et al. [33]
continued to take part in sport during the treatment period and this
could have neutralised the beneficial effects of ESWT. A similar non-
effective treatment was seen when eccentric exercises were used to
treat jumper’s knee during a competitive season [34]. So a period of
rest or restricting the subjects to minimal activities might be key in the
successful treatment of tendinopathies.
Similarly, none of the studies reported economic evaluations, which
should be considered to allow cost effectiveness decisions on treatment
recommendations [35-37].
Recommendations
Considering the cost and investment required for a shock wave
therapy machine and the findings of the review, careful consideration
should be given to the implementation of such interventions. Other
interventions like eccentric exercises may provide the same benefits as
of ESWT. Where ESWT is already in use, increased number of sessions
or co-interventions such as eccentric exercises might be required to
maintain its long-term effectiveness. It may also be important to
reduce loading of the tendon during the treatment phase by restricting
the patient to lighter activities. Careful consideration also should be
given when applying ESWT in older patients with degenerative
tendons as it might lead to ruptures.
Conclusion
We produced a review that expanded upon previous reviews and
addressed some methodological limitations. Studies were
heterogeneous but taken overall, the findings suggest that ESWT was
not able to demonstrate an improvement in outcomes compared to
other available treatments such as eccentric exercises. Well-designed
trials with optimised dosage and treatment protocols, adequate power,
longer term follow-up and economic analyses are required to establish
ESWT’s long-term effectiveness and cost effectiveness.
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